Ollie's combines a long store-expansion runway, strong cash generation and a compressed valuation with real rerating potential, though it must reverse negative comparable sales and prove margin strength outlasts tariff-refund benefits.
Medtronic offers improving growth, strong free cash flow, a durable regulatory and clinical moat and innovation catalysts, but moderate leverage and execution risk keep this Buy below the highest-conviction tier.
Broadcom is a high-ROIC infrastructure compounder whose custom AI accelerators, Ethernet networking and VMware cash engine can sustain exceptional growth, though hyperscaler concentration and a demanding valuation add downside if AI capex slows.
Futu is an astoundingly profitable, hyper-growth fintech compounder trading at distressed valuation multiples, yet investors must carefully navigate the extreme geopolitical crossfire between Chinese capital controls and US regulatory probes.
Agilent is a high-quality, cash-generative tollbooth in life sciences and analytical instruments with rapid margin expansion, though investors must accept a steep valuation premium amid cyclical biotech capex headwinds and China trade risk.
Scotiabank achieved its medium-term 14% ROE target early, driven by surging Global Banking and Wealth segments and Canadian margin expansion, though elevated PCLs and an aggressive buyback-driven CET1 reduction warrant continued monitoring.
Denison Mines offers non-dilutive exposure to the nuclear renaissance through its low-cost Phoenix ISR uranium project and fortress balance sheet, though pioneering freezing techniques in the Athabasca Basin carries severe binary execution risk.
LCI Industries is a brilliantly managed, cash-flowing tollbooth for the RV industry trading at a cyclical discount, but its near-term upside is entirely capped by the arbitrage math of its pending, regulator-scrutinized merger with Patrick Industries.
Analog Devices is a cash-generating juggernaut leveraging impenetrable analog switching costs to ride the AI infrastructure and industrial automation waves, though its pristine execution is fully priced into a multiple that leaves zero margin for macroeconomic error.
Delek US is an aggressively undervalued, high-yielding sum-of-the-parts play masking a pristine standalone balance sheet and a highly lucrative midstream asset, though investors must stomach the violent cyclicality of refining margins and persistent regulatory uncertainty.
BETA is constructing an impenetrable ecosystem moat by selling highly profitable charging infrastructure and components to its own competitors today, though investors must stomach extreme multiple volatility while awaiting binary FAA type certification for its flagship aircraft.
Atmus Filtration operates a wildly profitable, cash-printing aftermarket monopoly in heavy-duty commercial vehicles that trades at a steep discount to peers, though investors must remain acutely vigilant regarding the long-term existential decay of the global diesel engine market.